Orange Book product · Brand (NDA)

VAZALORE

ASPIRIN

Brand (NDA)NDA 203697OTC PLX PHARMA

Feb 26, 2021

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Feb 26, 2021
5 yr 5 mo ago
Today
Patent 10646431 expires
Listed drug product patent expiration.
Sep 29, 2032
in 6 yr 4 mo
Patent 10786444 expires
Listed method-of-use patent (U-3559) expiration.
Sep 29, 2032
in 6 yr 4 mo

Active ingredient

ASPIRIN

Strength

81MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 203697

Product number

002

Marketing status

OTC

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
10646431	Sep 29, 2032	in 6 yr 4 mo	Product
10786444	Sep 29, 2032	in 6 yr 4 mo	U-3559